Bicycle Therapeutics Plc ADR
(BCYC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 108,536 | 59,364 | 63,380 | 0 | 0 |
| Receivables | 9,895 | 8,331 | 11,313 | 0 | 0 |
| TOTAL | $120,452 | $69,919 | $76,769 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 2,002 | 1,801 | 1,818 | N/A | N/A |
| Other Non-Current Assets | 3,792 | 6,074 | 3,039 | 0 | 0 |
| TOTAL | $5,794 | $7,875 | $4,857 | $N/A | $N/A |
| Total Assets | $126,246 | $77,794 | $81,626 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,569 | 2,241 | 1,887 | 0 | 0 |
| Accrued Expenses | 5,859 | 6,154 | 7,032 | 0 | 0 |
| TOTAL | $9,440 | $8,419 | $8,929 | $0 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,012 | 24 | 10 | N/A | N/A |
| Other Non-Current Liabilities | 2,889 | 134,768 | 127,898 | 0 | 0 |
| TOTAL | $12,247 | $144,348 | $142,523 | $N/A | $N/A |
| Total Liabilities | $21,687 | $152,767 | $151,452 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,901 | N/A | N/A | N/A | N/A |
| Common Shares | 226 | 11 | 10 | 0 | 0 |
| Retained earnings | -86,662 | -76,445 | -69,942 | 0 | 0 |
| Other shareholders' equity | -2,183 | -671 | -1,751 | 0 | 0 |
| TOTAL | $104,559 | $-74,973 | $-69,826 | $0 | $0 |
| Total Liabilities And Equity | $126,246 | $77,794 | $81,626 | $0 | $0 |